Moreover, Pichiorri et al. [61] found that miR-221/222 expression is specifically modulated at the post-transcriptional level by nucleolin and demonstrated that targeting nucleolin effectively suppresses breast tumor malignancy. Here, NUCLEOLIN is linked to breast neoplasm.